Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 1Gastrointestinal Neoplasms 1Coitus 1

Interventions

pembrolizumab 1270Specimen Handling 921Magnetic Resonance Spectroscopy 832Carboplatin 829Cyclophosphamide 802Cisplatin 726Nivolumab 682Paclitaxel 639Radiotherapy 613Gemcitabine 578Biopsy 556Bevacizumab 477Dexamethasone 445fludarabine 405Docetaxel 382venetoclax 372Oxaliplatin 365Capecitabine 360Fluorouracil 358atezolizumab 345durvalumab 338Rituximab 336Drug Therapy 330Doxorubicin 319Radiosurgery 316Blood Specimen Collection 313Pemetrexed 308Standard of Care 306Ipilimumab 305Radiation 285

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Proctectomy × 1 year × Clear all
NCT03594630 2026-05-20

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Recruiting
120 enrolled
Gastrointestinal

Rectal Neoplasms

NCT07017712 2025-06-12

SeDiGCS

Medizinische Hochschule Brandenburg Theodor Fontane

Completed
870,754 enrolled
Gastrointestinal

Coitus, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡